MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹6,022 Cr | ₹8,300 Cr | ₹196 Cr | ₹163 Cr | ₹868 Cr |
What is the latest Total Debt ratio of MANKIND PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹6,022 Cr |
| Mar2025 | ₹8,300 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹163 Cr |
| Mar2022 | ₹868 Cr |
How is Total Debt of MANKIND PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,022 Cr | -27.45 | |
| Mar2025 | ₹8,300 Cr | 4,134.07 | |
| Mar2024 | ₹196 Cr | 20.54 | |
| Mar2023 | ₹163 Cr | -81.26 | |
| Mar2022 | ₹868 Cr | - | |
Compare Total Debt of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹105,979.9 Cr | 1.4% | 6.7% | -3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.4% |
6.7% |
-3.4% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses